6 November 2021 Current Affairs India's target of net-zero emissions set to which year? 2070 2080 2060 2050 2070 2080 2060 2050 ANSWER EXPLANATION DOWNLOAD EXAMIANS APP India's target of net-zero emissions by 2070 is a long way off.
6 November 2021 Current Affairs Who initiated the "Jai Bhim Mukhyamantri Pratibha Vikas Yojana" Scheme? Maharashtra Government Indian Government Delhi Government Gujarat Government Maharashtra Government Indian Government Delhi Government Gujarat Government ANSWER EXPLANATION DOWNLOAD EXAMIANS APP The Delhi government initiated this scheme. It was started at a few private facilities for a variety of competitive tests.
6 November 2021 Current Affairs How many students enrolled in Jai Bhim Mukhyamantri Pratibha Vikas Yojana coaching classes in 2021? 10000 1500 5000 15000 10000 1500 5000 15000 ANSWER EXPLANATION DOWNLOAD EXAMIANS APP Around 15,000 students have enrolled for coaching classes in the year 2021, under the "Jai Bhim Mukhyamantri Pratibha Vikas Yojana" Scheme.
6 November 2021 Current Affairs Who has won the 2021 Booker Prize? Damon Galgut Paulo Coelho Khaled Hosseini Nguyen Phan Que Mai Damon Galgut Paulo Coelho Khaled Hosseini Nguyen Phan Que Mai ANSWER EXPLANATION DOWNLOAD EXAMIANS APP South African novelist Damon Galgut won the 2021 Booker Prize for his novel 'The Promise'.
6 November 2021 Current Affairs How much amount is set up as the first 'loss risk-sharing instrument' by NITI Aayog and the World Bank? $33 Million $30 Million $300 Million $3 Million $33 Million $30 Million $300 Million $3 Million ANSWER EXPLANATION DOWNLOAD EXAMIANS APP The two entities are setting up a $300-million 'first loss risk-sharing instrument', with the State Bank of India (SBI) as its programme manager.
6 November 2021 Current Affairs Which is the first country to approve Merck's Oral Covid Pill? China USA UK India China USA UK India ANSWER EXPLANATION DOWNLOAD EXAMIANS APP Britain has become the first country in the world to approve a potentially game-changing Covid-19 antiviral pill jointly developed by the U.S -based Merch and Ridgeback Biotherapeutics, in a boost to the fight against the pandemic.
EXAMIANS